- For DC participants
- For some European scientists
- For selected ESPID members
- For two young American vaccinologists (NFID)
The course aims to facilitate critical decision making in vaccinology by providing participants with a comprehensive overview of the field,...Read more...
Who should apply ?
Who should apply?
This advanced course is for scientists and decision-makers involved in vaccine development, in the elaboration of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes, at national or international levels. It is relevant for both the public and private sectors.
Participants (maximum 60) will be selected by an International scientific committee, according to their: Educational background, Involvement in vaccinology. Decision-making responsibility in vaccinology. Expected impact of the course at personal, institutional and national levels.Read more...
ADVAC: a two-week training programme for decision-makers, including academia, industry, governmental and non-governmental agencies, in all fields related to vaccines and vaccination, vaccine trials, new vaccines, vaccination strategies and policies, vaccine-specific issues (including hepatitis, meningitis, polio, measles, pneumococcal diseases, influenza, malaria, HIV and AIDS, tuberculosis, HPV, rotavirus, dengue & JE), ethical issues related to vaccine trials, financing of immunization policy, communication
Over 60 top-level international lecturers and working group supervisors, all experts in vaccinology
ADVAC has been awarded 60 CME credits by the EACCME (European Accreditation Council for Continuing Medical Education (These credits can also be validated in USA)
2013 Course: From 6 to 17 May 2013. The on-line application process is now closed.
Practical information on the location of the Advanced Course of Vaccinology at Les Pensières ( http://www.fondation-merieux.org/?-Presentation,373-) can be obtained on the Fondation Mérieux website.
ADVAC is co-sponsored by:
Unrestricted education grants are provided by
- The European Commission -ADITEC project
- Fondation Mérieux
- University of Geneva
- World Health Organization
- Centers for Disease Control (CDC)
- European Society for Pediatric Infectious (ESPID)
- European Centre for Disease Prevention and Control (ECDC)
- Johns Hopkins Bloomberg School of Public Health
- National Institutes of Health (NIH/NIAID-USA) and Fogarty International Center
- National Foundation for Infectious Diseases (NFID)
- National Vaccine Programme Office (NVPO)
GlaxoSmithKline • Novartis Vaccines • Sanofi Pasteur • Sanofi Pasteur MSD • Vaxinnate • Pfizer • Crucell . Serum Institute of India